Report Highlights
The global market for centrifugation in life sciences should grow from $3.5 billion in 2021 to $5.1 billion by 2026, at compound annual growth rate (CAGR) of 7.6% for the period of 2021-2026.
Report Includes
- 50 tables
- An overview of the global centrifugation market
- Estimation of the market size and analyses of global market trends, with data from 2019, 2020, 2021 and projections of compound annual growth rates (CAGRs) through 2026
- Highlights of the market potential for centrifugation market based on product type, model type, application, end use, and region
- Detailed overview of centrifugation process, basics, and types of centrifugation separations; and information on centrifuges used in pharmaceutical manufacturing
- Discussion on applications of centrifuges in pharmaceutical companies and description of centrifuges used for RTPCR testing of COVID-19
- Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size and forecast, and assessment of new developments in the industry
- Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies
- Comprehensive company profiles of the leading players including Alfa Laval AB, Beckman Coulter Inc., Cardinal Health, Eppendorf, GEA Group AG, and Sartorius AG
Report Scope
This report provides a detailed description of centrifugation in life sciences and the latest technologies in the market. The report includes market estimates for different types of centrifugation in life sciences. The report also includes recent technological developments and assessments of product performance in the market.
By product type, the global market for centrifugation in life sciences is segmented into disc stack centrifuges, high-speed centrifuges, high-capacity centrifuges, multipurpose centrifuges, microcentrifuges, blood banking centrifuges and ultracentrifuges.
By model type, the global market for centrifugation in life sciences is segmented into benchtop centrifuges and floor-standing centrifuges.
By application, the global market for centrifugation in life sciences is segmented into bio-pharmaceuticals and clinical diagnostics.
By end use, the global market for centrifugation in life sciences is segmented into lab scale and production scale.
This report discusses the qualitative and quantitative factors influencing market growth. Market drivers, restraints and opportunities are discussed in the report.
This report discusses some of the major drivers and restraints in the global market for centrifugation in life sciences, as well as competition and key player strategies and performance. The discussion is focused on major market players, trends in product launches, collaborations and mergers and acquisitions. The report also emphasizes company profiles for major vendors, including company overview, key product offerings, financial statistics and recent developments. The report provides insights on market share and upcoming regional demand for centrifugation in life sciences.
Some of the major market players discussed in the report are Thermo Fisher Scientific Inc., Beckman Coulter Inc. (Danaher Corporation) and Eppendorf AG, NuAire, Alfa Laval Corporate AB and GEA Group AG. For market estimates, data has been provided for 2019 as the base year, with forecasts for 2021 through 2026. Estimated values used are based on manufacturer total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.
Report Synopsis
| Report Metrics | Details | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2019 | ||||||||||||||
| Forecast period considered | 2021-2026 | ||||||||||||||
| Base year market size | $3.0 billion | ||||||||||||||
| Market size forecast | $5.0 billion | ||||||||||||||
| Growth rate | CAGR of 7.6% from 2021 to 2026 | ||||||||||||||
| Units considered | $ Millions | ||||||||||||||
| Segments covered | Product Type, Model Type, Application, End Use | ||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, Rest of the World (RoW) | ||||||||||||||
| Countries covered | U.S., Canada, Germany, France, U.K., Italy, Spain, Switzerland, Denmark, Norway, Poland, Belgium, Austria, Netherlands, Sweden, Japan, China, India, Australia, New Zealand, Taiwan, Singapore, Malaysia, Thailand, Philippines, Korea, etc., Latin America, Middle East and North Africa, Sub-Saharan Africa | ||||||||||||||
| Key Market Drivers |
|
||||||||||||||
| Companies studied |
|
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Global Sustainable Marine Fuel Market (EGY198A)
- Gene Synthesis: Technologies and Global Markets (BIO251A)
- Water Filtration: Global Markets (MST080B)
- Flow Cytometry: Products, Technologies and Global Markets (BIO085F)
- Global Crop Protection Chemicals Market (CHM188A)
Related Reports
Global Markets for Vaccine Technologies
The global market for vaccine technologies is expected to grow from $45.0 billion in 2023 to $65.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.8% from 2023 to 2028.
Needle-Free Devices: Technologies and Global Markets
The global market for needle-free devices should grow from $3.0 billion in 2018 to $4.6 billion by 2023, increasing at a compound annual growth rate (CAGR) of 9.3% from 2018 to 2023.
Recent Reports
Gene Synthesis: Technologies and Global Markets
The global market for Gene Synthesis is estimated to increase from $2.0 billion in 2023 to reach $4.1 billion by 2028, at a compound annual growth rate (CAGR) of 15.8% from 2023 through 2028.
Flow Cytometry: Products, Technologies and Global Markets
The global market for flow cytometry products is expected to grow from $5.2 billion in 2023 to $8.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2029.
PEGylated Proteins Market
The global market for PEGylated proteins is expected to grow from $10.2 billion in 2023 and projected to reach $15.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.4% during the forecast period of 2023 to 2028.
Companion Diagnostics: Technologies and Markets
The global market for companion diagnostics is estimated to increase from $7.6 billion in 2023 to reach $15.4 billion by 2028, at a compound annual growth rate (CAGR) of 15.2% from 2023 through 2028.
Exosome Diagnostics, Therapeutics and Research Tools: Global Markets
The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.
Top Trending Reports
Global Market for Cell and Gene Therapy
The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028.
Peptide Synthesis: Global Markets
The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.
Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets
The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.
Oligonucleotides: Global Markets
The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.
3D Cell Cultures: Technologies and Global Markets
The global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028, at a compound annual growth rate (CAGR) of 26.5% from 2023 through 2028.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More